Evidence map›Paper›PMID 41241908›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Functional Validation of Transcriptionally Active Microproteins/sORFs In Planta.

Ashish Sharma, Prabodh Kumar Trivedi

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ashish SharmaCSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India.
Prabodh Kumar TrivediCSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP), Lucknow, Uttar Pradesh, India. prabodht@nbri.res.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advancements in biotechnology, bioinformatics tools, and high-throughput sequencing techniques have greatly enhanced our ability to identify small but significant molecules in plants that were previously thought to be junk. Small molecules, including microproteins (miPs) and micoRNA-encoded peptides (miPEPs), play a crucial role in various aspects of plant biology, such as growth, development, stress responses, hormonal signaling, and primary and secondary metabolism. Despite their importance, many of these molecules still need to be characterized due to the challenges associated with validating them in plants. Traditional validation methods, like protein sequencing and western blotting using specific antibodies, are often expensive and labor-intensive, which limits their use in large-scale studies. To address these challenges, alternative methods like promoter-reporter lines linked to a reporter gene such as β-glucuronidase (GUS) can offer a more efficient and cost-effective solution to validate transcriptionally active small peptides/ORFs in planta. The GUS assay allows for the direct visualization of gene activity in plant tissues, simplifying the validation of candidate molecules (small peptides/ORFs) and alternative transcripts. This approach speeds up the functional characterization of novel genes and molecules, ultimately advancing plant research and biotechnology applications focused on their functional characterization.

Indexed as

ArabidopsisPeptidesPlant ProteinsPlantsGene Expression Regulation, PlantGenes, ReporterGlucuronidaseMicropeptidesPlants, Genetically ModifiedPromoter Regions, GeneticGlucuronidaseMicropeptidesPeptidesPlant ProteinsAlternative transcriptGUS (β-glucuronidase)Hormonal signallingMicroproteinsmiPEPORFSmall peptidesStress responses

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.